BBH ETF holdings
VanEck Biotech ETF (BBH). Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
- Fund: Reported value VanEck Biotech ETF.
- Report date: Reported value 2026-03-31.
- Reported holdings: Reported value 25.
- SEC series ID: Reported value S000034406.
| Snapshot field | Reported value |
|---|
| Fund | VanEck Biotech ETF |
|---|
| Report date | 2026-03-31 |
|---|
| Reported holdings | 25 |
|---|
| SEC series ID | S000034406 |
|---|
Positions 1–25 of 25
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| Gilead Sciences Inc | Gilead Sciences Inc | 14.63083021743% | 54,367,122.04 | 390,092 NS |
|---|
| Amgen Inc | Amgen Inc | 14.5422129791% | 54,037,826.7 | 153,582 NS |
|---|
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | 8.057702115836% | 29,941,846.62 | 67,053 NS |
|---|
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | 7.512799805102% | 27,917,028.48 | 36,132 NS |
|---|
| Argenx SE | Argenx SE | 5.276923896046% | 19,608,673 | 26,852 NS |
|---|
| Insmed Inc | Insmed Inc | 4.5892970872% | 17,053,500.8 | 104,290 NS |
|---|
| IQVIA Holdings Inc | IQVIA Holdings Inc | 4.298048426426% | 15,971,241.54 | 93,651 NS |
|---|
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | 4.106570818608% | 15,259,724.4 | 46,120 NS |
|---|
| Natera Inc | Natera Inc | 3.978940891569% | 14,785,460.69 | 73,931 NS |
|---|
| United Therapeutics Corp | United Therapeutics Corp | 3.806889740946% | 14,146,130.88 | 23,856 NS |
|---|
| Biogen Inc | Biogen Inc | 3.722074957163% | 13,830,965.19 | 75,443 NS |
|---|
| BeOne Medicines Ltd | BeOne Medicines Ltd | 3.246433471962% | 12,063,515.34 | 40,622 NS |
|---|
| Moderna Inc | Moderna Inc | 3.102058436264% | 11,527,028 | 226,910 NS |
|---|
| Revolution Medicines Inc | Revolution Medicines Inc | 2.862204063421% | 10,635,746.25 | 109,365 NS |
|---|
| Illumina Inc | Illumina Inc | 2.492215084164% | 9,260,893.58 | 75,133 NS |
|---|
| Incyte Corp | Incyte Corp | 2.248335900521% | 8,354,655.92 | 88,766 NS |
|---|
| BioNTech SE | BioNTech SE | 2.154520279365% | 8,006,043.76 | 90,077 NS |
|---|
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | 1.936714421555% | 7,196,692.72 | 54,628 NS |
|---|
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | 1.392468729985% | 5,174,314.53 | 91,597 NS |
|---|
| Bio-Techne Corp | Bio-Techne Corp | 1.347352215883% | 5,006,664.78 | 95,803 NS |
|---|
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | 1.278409213993% | 4,750,477.5 | 27,539 NS |
|---|
| ICON PLC | ICON PLC | 1.272137936521% | 4,727,173.88 | 42,718 NS |
|---|
| QIAGEN NV | QIAGEN NV | 1.145504312234% | 4,256,612.36 | 106,309 NS |
|---|
| Tempus AI Inc | Tempus AI Inc | 0.926991277241% | 3,444,633.5 | 76,175 NS |
|---|
| State Street Global Advisors | State Street Global Advisors | 0.229604176193% | 853,192.75 | 853,192.75 NS |
|---|